Review of clinical trial settings of drugs commonly used in primary care and approved between 2005 and 2012

J Gen Intern Med. 2018 Sep;33(9):1431-1432. doi: 10.1007/s11606-018-4486-7.

Jason R Crossley¹, Tina P Tan², Keisha Herbin Smith², Joseph S Ross^{3

4

5}, Daniel J Merenstein⁶

¹ Georgetown University School of Medicine, Washington, DC, USA.
² Department of Family Medicine, Georgetown University Medical Center, Washington, DC, USA.
³ The Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA.
⁴ Section of General Internal Medicine and the National Clinician Scholars Program, Department of Medicine, Yale School of Medicine, New Haven, CT, USA.
⁵ Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA.
⁶ Department of Family Medicine, Georgetown University Medical Center, Washington, DC, USA. djm23@georgetown.edu.

No abstract available

Keywords: FDA; Pivotal studies; Primary care.

Publication types